j 2023

Editorial: COVID-19 Vaccines Safety Tracking (CoVaST): Part I

KLUGAR, Miloslav, Sameh ATTIA, Giordano PÉREZ-GAXIOLA, Tina POKLEPOVIĆ PERIČIĆ, Janja MARC et. al.

Basic information

Original name

Editorial: COVID-19 Vaccines Safety Tracking (CoVaST): Part I

Authors

KLUGAR, Miloslav, Sameh ATTIA, Giordano PÉREZ-GAXIOLA, Tina POKLEPOVIĆ PERIČIĆ, Janja MARC and Abanoub RIAD

Edition

Frontiers in Public Health, LAUSANNE, FRONTIERS MEDIA SA, 2023, 2296-2565

Other information

Language

English

Type of outcome

Článek v odborném periodiku (nerecenzovaný)

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.200 in 2022

Organization unit

Faculty of Medicine

DOI

UT WoS

000946523900001

Tags

International impact
Změněno: 14/3/2024 12:24, Mgr. Tereza Miškechová

Abstract

V originále

Acceleration of coronavirus disease (COVID-19) mass vaccination has been a chief priority for health systems globally since the first emergency approvals of COVID-19 vaccines in late 2020. Nevertheless, vaccine hesitancy (VH), which is nourished by misinformation about vaccines' effectiveness and safety, remains as a serious threat for vaccination strategies worldwide. Aversion to post-vaccination side effects, the lack of trust of pharmaceutical industry, and the lack of knowledge about vaccines' safety are among the VH drivers; therefore independent (non-sponsored) and active surveillance of COVID-19 vaccines safety is of utmost importance for suppressing VH.